The University of Chicago Header Logo

Connection

Kourosh Rezania to Amyotrophic Lateral Sclerosis

This is a "connection" page, showing publications Kourosh Rezania has written about Amyotrophic Lateral Sclerosis.
  1. Intermuscular coherence from muscle pairs in the leg as a biomarker for amyotrophic lateral sclerosis. Clin Neurophysiol. 2025 Nov; 179:2110986.
    View in: PubMed
    Score: 0.848
  2. Intermuscular coherence as an early biomarker for amyotrophic lateral sclerosis: The protocol for a prospective, multicenter study. PLoS One. 2024; 19(5):e0303053.
    View in: PubMed
    Score: 0.777
  3. Gastrostomy tube placement is safe in advanced amyotrophic lateral sclerosis. Neurol Res. 2017 Jan; 39(1):16-22.
    View in: PubMed
    Score: 0.462
  4. Venous thromboembolism after diaphragm pacing in amyotrophic lateral sclerosis. Muscle Nerve. 2014 Nov; 50(5):863-5.
    View in: PubMed
    Score: 0.398
  5. Home-Based Tele-tDCS in Amyotrophic Lateral Sclerosis: Feasibility, Safety, and Preliminary Efficacy. Ann Clin Transl Neurol. 2025 May; 12(5):1022-1033.
    View in: PubMed
    Score: 0.206
  6. Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial. JAMA Neurol. 2025 04; 82(4):333-343.
    View in: PubMed
    Score: 0.205
  7. Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Netw Open. 2025 02 03; 8(2):e2459058.
    View in: PubMed
    Score: 0.204
  8. A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset, incomplete penetrance and a sensory neuropathy. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep; 4(3):162-6.
    View in: PubMed
    Score: 0.185
  9. Neurophysiological features of primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020 11; 21(sup1):11-17.
    View in: PubMed
    Score: 0.152
  10. Preface: promoting research in PLS: current knowledge and future challenges. Amyotroph Lateral Scler Frontotemporal Degener. 2020 11; 21(sup1):1-2.
    View in: PubMed
    Score: 0.152
  11. A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2021 05; 22(3-4):287-299.
    View in: PubMed
    Score: 0.151
  12. Intermuscular coherence in amyotrophic lateral sclerosis: A preliminary assessment. Muscle Nerve. 2017 06; 55(6):862-868.
    View in: PubMed
    Score: 0.117
  13. Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis. J Clin Pharmacol. 2014 Oct; 54(10):1180-7.
    View in: PubMed
    Score: 0.097
  14. Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PLoS One. 2013; 8(4):e61177.
    View in: PubMed
    Score: 0.090
  15. Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol. 2009 Aug; 66(2):235-44.
    View in: PubMed
    Score: 0.070
  16. A clinical trial of creatine in ALS. Neurology. 2004 Nov 09; 63(9):1656-61.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.